187 related articles for article (PubMed ID: 3624505)
1. Imipramine blood levels and clinical outcome.
Rigal JG; Albin HC; Duchier AR; D'Aulnay JM; Fenelon JH; Vincon GA; Demotes-Mainard FM
J Clin Psychopharmacol; 1987 Aug; 7(4):222-9. PubMed ID: 3624505
[TBL] [Abstract][Full Text] [Related]
2. [Clinical usefulness of monitoring serum levels of imipramine and desipramine in patients treated for endogenous depression].
Szymura-Oleksiak J; Wasieczko A
Psychiatr Pol; 1991; 25(1):54-60. PubMed ID: 1780375
[TBL] [Abstract][Full Text] [Related]
3. The pharmacotherapy of depressive illness in adolescence: I. An open label trial of imipramine.
Strober M; Freeman R; Rigali J
Psychopharmacol Bull; 1990; 26(1):80-4. PubMed ID: 2196630
[TBL] [Abstract][Full Text] [Related]
4. Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients.
Sutfin TA; Perini GI; Molnar G; Jusko WJ
J Clin Psychopharmacol; 1988 Feb; 8(1):48-53. PubMed ID: 3350999
[TBL] [Abstract][Full Text] [Related]
5. Depression in children: relationship between plasma imipramine levels and response.
Preskorn SH; Weller EB; Weller RA
J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment with imipramine and mianserin. A controlled pilot study.
Lauritzen L; Clemmesen L; Klysner R; Loldrup D; Lunde M; Schaumburg E; Waarst S; Bech P
Pharmacopsychiatry; 1992 Jul; 25(4):182-6. PubMed ID: 1528957
[TBL] [Abstract][Full Text] [Related]
7. Effects of joint administration of imipramine and amantadine in patients with drug-resistant unipolar depression.
Rogóz Z; Dziedzicka-Wasylewska M; Daniel WA; Wójcikowski J; Dudek D; Wróbel A; Zieba A
Pol J Pharmacol; 2004; 56(6):735-42. PubMed ID: 15662086
[TBL] [Abstract][Full Text] [Related]
8. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
[TBL] [Abstract][Full Text] [Related]
9. Prediction of steady-state plasma levels of doxepin and imipramine from single dose levels in depressed outpatients.
Hrdina PD; Bakish D; Swenson S; Lapierre YD
J Psychiatry Neurosci; 1991 Mar; 16(1):25-9. PubMed ID: 2049367
[TBL] [Abstract][Full Text] [Related]
10. The influence of the route of administration of imipramine on imipramine and desipramine blood levels.
Rigal J; Albin H; Fança X; Demotes-Mainard F; Vinçon G
J Clin Psychopharmacol; 1989 Oct; 9(5):364-7. PubMed ID: 2677063
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome and adverse effect profile associated with concurrent administration of alprazolam and imipramine.
Wells BG; Evans RL; Ereshefsky L; Antal EJ; Lobeck F; Rawls WN; Hamann G; Grimmig J; Smith RB
J Clin Psychiatry; 1988 Oct; 49(10):394-9. PubMed ID: 3049560
[TBL] [Abstract][Full Text] [Related]
12. Kinetic effects of desmethylimipramine treatment on platelet serotonin uptake in depressed patients: a comparison with imipramine.
Rausch JL; Moeller FG
Psychiatry Res; 1991 Mar; 36(3):299-305. PubMed ID: 2062971
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of imipramine in psychotic versus nonpsychotic depression.
Birkenhager TK; van den Broek WW; Mulder PG; Moleman P; Bruijn JA
J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
[TBL] [Abstract][Full Text] [Related]
14. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E
J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
[TBL] [Abstract][Full Text] [Related]
15. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
[TBL] [Abstract][Full Text] [Related]
16. Double-blind comparison of amoxapine and imipramine in the treatment of depressed patients.
Gelenberg AJ; Wojcik JD; Lydiard RB; McCormick MG; Falk WE; Hicks RH; Curren FC; Cohen BM
J Clin Psychiatry; 1984 Feb; 45(2):54-56, 57-9. PubMed ID: 6363397
[TBL] [Abstract][Full Text] [Related]
17. Targeting imipramine dose in children with depression.
Sallee F; Stiller R; Perel J; Rancurello M
Clin Pharmacol Ther; 1986 Jul; 40(1):8-13. PubMed ID: 3720179
[TBL] [Abstract][Full Text] [Related]
18. Possible nonlinear pharmacokinetics of desipramine after once daily dosing.
Amsterdam JD; Brunswick DJ; Potter L; Rickels K
Pharmacopsychiatry; 1986 Mar; 19(2):84-7. PubMed ID: 3703927
[TBL] [Abstract][Full Text] [Related]
19. Endogenous depression and imipramine levels in the blood.
Costa D; Predescu V; Vişan-Ionescu I; Ciurezu T
Psychopharmacology (Berl); 1980; 70(3):291-4. PubMed ID: 6777803
[TBL] [Abstract][Full Text] [Related]
20. Nomifensine vs. imipramine in depressed inpatients.
Fann WE; Lyle FA; Higginbotham W
J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):60-2. PubMed ID: 6370978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
